Nayan Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Nayan Therapeutics General Information

Description

Operator of a preclinical-stage biotech company intended to develops mutation-agnostic therapies to treat inherited retinal diseases. The company is currently operating in Stealth Mode.

Contact Information

Formerly Known As
PhotoRegulon Therapeutics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 266 Main Street Building 2
  • Suite 11
  • Medfield, MA 02052
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 266 Main Street Building 2
  • Suite 11
  • Medfield, MA 02052
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nayan Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 31-Jul-2020 Completed Out of Business
1. Early Stage VC (Series A) 13-Feb-2019 Completed Stealth
To view Nayan Therapeutics’s complete valuation and funding history, request access »

Nayan Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Nayan Therapeutics’s complete cap table history, request access »

Nayan Therapeutics Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Nayan Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022026719-A2 Nrl antisense oligonucleotides, compositions containing the same, and methods of their use Inactive 29-Jul-2020
WO-2022026719-A3 Nrl antisense oligonucleotides, compositions containing the same, and methods of their use Inactive 29-Jul-2020
CA-3127483-A1 Nr2e3 expression reducing oligonucleotides, compositions containing the same, and methods of their use Pending 25-Jan-2019
EP-3914712-A1 Nr2e3 expression reducing oligonucleotides, compositions containing the same, and methods of their use Inactive 25-Jan-2019
US-20220098595-A1 Nr2e3 expression reducing oligonucleotides, compositions containing the same, and methods of their use Inactive 25-Jan-2019 C12N15/1138
To view Nayan Therapeutics’s complete patent history, request access »

Ready to get started?

Request a free trial

Nayan Therapeutics FAQs

  • When was Nayan Therapeutics founded?

    Nayan Therapeutics was founded in 2018.

  • Where is Nayan Therapeutics headquartered?

    Nayan Therapeutics is headquartered in Medfield, MA.

  • What industry is Nayan Therapeutics in?

    Nayan Therapeutics’s primary industry is Drug Discovery.

  • Is Nayan Therapeutics a private or public company?

    Nayan Therapeutics is a Private company.

  • What is Nayan Therapeutics’s current revenue?

    The current revenue for Nayan Therapeutics is .

  • How much funding has Nayan Therapeutics raised over time?

    Nayan Therapeutics has raised $3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process